While the industry is just beginning to unlock the clinical benefits of cell therapy, developers of next-gen CAR T-cell and TCR-based therapies depend on a fast and reliable supply of DNA to treat patients who cannot afford to wait. Our innovative cell-free gene synthesis platform delivers long, complex, high-accuracy DNA in days, to save you weeks. Stop by Booth #2 at the 9th Annual CAR-TCR Summit Series conference, Sep 18-19 in Boston, to learn how Elegen can accelerate your cell therapy development. Register: https://hubs.ly/Q02MKgsq0 #CART #TCR #cellandgene #genesynthesis
ELEGEN
Biotechnology
San Carlos, California 5,154 followers
Unlock the promise of synthetic biology by accelerating the Design-Build-Test-Learn cycle
About us
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges. Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.
- Website
-
http://www.elegenbio.com
External link for ELEGEN
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- San Carlos, California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- microfluidics, hardware, synthetic biology, engineering, organic chemsitry, DNA Synthesis, molecular biology, and biology
Locations
-
Primary
1300 Industrial Rd
San Carlos, California 94070, US
Employees at ELEGEN
Updates
-
ICYMI: Trials of the world's first mRNA lung cancer vaccine for non-small cell lung cancer (#NSCLC) have begun! Phase 1 clinical trials of BioNTech SE's #BNT116 vaccine have started in the UK, US, Germany, Hungary, Poland, Spain and Turkey. If you're developing mRNA vaccines & therapies, ELEGEN's next-gen, cell-free #genesynthesis platform will save you weeks of time and resources. Read more https://hubs.ly/Q02MznMg0 #cellfreecloning #DNAinnovation #EnfiniaDNA #syntheticDNA #biotech
-
Meet our latest #TechTalent @Aleia Mouchref, Laboratory Automation Engineer! Armed with experience at several Big Pharma, she carries a passion for automation development and engineering workflows. So happy to have you join us! #SanFrancisco #BayAreaJobs #hiring #TeamGrowth
-
-
The stakes are high to bring new mRNA medicines and therapies to market faster. That’s why we innovated the DNA build process to be cell-free: To provide long, complex, high-accuracy template DNA to eliminate cloning and its associated time and resources, saving you weeks. Stop and see us, Booth 13, at the RNA Leaders USA Congress Sep 4-5 in San Diego. https://hubs.ly/Q02L9yWV0 #mRNAvaccines #mRNAtheraeutics #DNAinnovation #RNAleaders #IVTready
-
-
We are #hiring across our R&D, Operations, and Marketing departments. We take pride in building a great team–our employees consistently rank the people and camaraderie as a favorite factor in their jobs (see https://bit.ly/4dp5azg)! If you’re interested in joining a team that values your creativity and growth, check out these openings: https://bit.ly/3yCNcde #biotech #SanFrancisco #BayAreaJobs #genesynthesis
-
-
Please help us welcome @Rogelio Denegri as Lab Manager to #TeamElegen! Regelio brings with him well over a decade of lab and plant management experience–a great fit as ELEGEN's labs expand! #WelcomeAboard! #SanFrancisco #BayAreaJobs #hiring #WeAreGrowing
-
-
We're #hiring a new Senior Product Manager in San Francisco, California. Apply today or share this post with your network.
-
Congrats Jason Yang and the Caltech team! ELEGEN was happy to deliver the sequence-perfect genes within a week to accelerate the optimization! We look forward to seeing the final publication. https://lnkd.in/gMGfyDAc
Jason Yang (@jsunn_y) on X
x.com
-
This month we spotlight a valuable member of our R&D team, igor rupniewski, Senior Scientist, Molecular Biology. Igor works on the development of ELEGEN's core technologies and is inspired by customer feedback and improving product quality. We’re #LuckytoHaveYou on #TeamElegen! Read more about Igor: https://bit.ly/3SOUukZ #EmployeeSpotlight #Hiring #BayAreaJobs #SanFrancisco
-
-
Conventional cell-based cloning workflows can take 3-6 wks to produce template DNA ready for #IVT. #EnfiniaDNA’s advanced cell-free gene synthesis is ready within ~1 week to provide a rapid, reliable way to expedite #mRNAtherapy dev. Check out this poster and compare!
What is the key to faster, reliable mRNA vaccine production? Discover how cutting-edge cell-free gene synthesis technology speeds up mRNA production and the development of life saving vaccines and therapeutics. Download this poster from ELEGEN: https://ow.ly/vqYS50STkL4 #Ad
-